Page last updated: 2024-08-26

eudragit rs and HIV Coinfection

eudragit rs has been researched along with HIV Coinfection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cazorla-Luna, R; Martín-Illana, A; Notario-Pérez, F; Rubio, J; Ruiz-Caro, R; Tamayo, A; Veiga, MD1
Bedoya, LM; Cazorla-Luna, R; Martín-Illana, A; Notario-Pérez, F; Rubio, J; Ruiz-Caro, R; Tamayo, A; Veiga, MD1

Other Studies

2 other study(ies) available for eudragit rs and HIV Coinfection

ArticleYear
Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV.
    Carbohydrate polymers, 2018, Jan-01, Volume: 179

    Topics: Acrylic Resins; Administration, Intravaginal; Animals; Chitosan; Delayed-Action Preparations; Female; Galactans; HIV Infections; Humans; Hypromellose Derivatives; Mannans; Mucous Membrane; Plant Gums; Reverse Transcriptase Inhibitors; Tablets; Tenofovir

2018
Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV.
    Marine drugs, 2017, Feb-21, Volume: 15, Issue:2

    Topics: Acrylic Resins; Adhesives; Animals; Cattle; Cell Line; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Female; Galactans; HIV Infections; Humans; Hypromellose Derivatives; Mannans; Mucous Membrane; Plant Gums; Polymers; Sexually Transmitted Diseases; Tablets; Tenofovir; Vagina

2017